Polymorphism in the cholesteryl ester transfer protein gene and the risk of early onset myocardial infarction among cigarette smokers

Annals of Noninvasive Electrocardiology

Volumn 12, Issue 4, 2007, Pages 364-374

  Goldenberg, Ilan ^a,b   Moss, Arthur J ^a   Block, Robert ^a   Ryan, Daniel ^a   Corsetti, James P ^a   McNitt, Scott ^a   Eberly, Shirley W ^a   Zareba, Wojciech ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Myocardial infarction; Single nucleotide polymorphism; Smoking

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HEREDITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANALYSIS OF VARIANCE; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SMOKING;

EID: 35548972906     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2007.00186.x     Document Type: Article

References (29)

1. Escobedo LG, Zack MM. Comparison of sudden and nonsudden coronary deaths in the United States. Circulation 1996 93 : 2033 2036.
2. Salonen JT. Stopping smoking and long-term mortality after acute myocardial infarction. Br Heart J 1980 43 : 463 469.
3. Gordon T, Kannel WB, McGee D, et al. Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. Lancet 1974 2 : 1345 1348.
4. Slone D, Shapiro S, Rosenberg L, et al. Relation of cigarette smoking to myocardial infarction in young women. N Engl J Med 1978 298 : 1273 1276.
5. Rosenberg L, Kaufman DW, Helmrich SP, et al. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 1985 313 : 1511 1514.
6. Gottlieb S, Fallavollita J, McDermott M, et al. Cigarette smoking and the age at onset of a first non-fatal myocardial infarction. Coron Artery Dis 1994 5 : 687 694.
7. Bolego C, Poli A, Paoletti R. Smoking and gender. Cardiovasc Res. 2002 53 : 568 576.
8. Cullen P, Schulte H, Assmann G. Smoking, lipoproteins and coronary heart disease risk. Data from the Munster Heart Study (PROCAM). Eur Heart J 1998 19 : 1632 1641.
9. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989 79 : 8 15.
10. Jacobs DR, Jr., Mebane IL, Bangdiwala SI, et al. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: The follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990 131 : 32 47.
11. Barter PJ, Brewer HB, Jr., Chapman MJ, et al. Cholesteryl ester transfer protein: A novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003 23 : 160 167.
12. Tall A. Plasma lipid transfer proteins. Annu Rev Biochem 1995 64 : 235 257.
13. Collet X, Tall AR, Serajuddin H, et al. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I. J Lipid Res 1999 40 : 1185 1193.
14. Brinton EA, Eisenberg S, Breslow JL. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb 1994 14 : 707 720.
15. Kondo I, Berg K, Drayna D, et al. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet 1989 35 : 49 56.
16. Boekholdt SM, Sacks FM, Jukema JW, et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: Individual patient meta-analysis of 13,677 subjects. Circulation 2005 111 : 278 287.
17. Dullaart RP, Hoogenberg K, Dikkeschu BD, et al. High plasma lipid transfer protein activities and unfavourable lipoprotein changes in cigarette smoking men. Arterioscler Thromb 1994 14 : 1581 1585.
18. Moss AJ, Goldstein RE, Marder VJ, et al. Thrombogenic risk factors and recurrent coronary events. Circulation 1999 99 : 2517 2522.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
20. Rainwater DL, Moore PH Jr., Shelledy WR, et al. Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins. J Lipid Res 1997 38 : 1261 1266.
21. Ordovas JM, Cupples LA, Corella D, et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: The Framingham study. Arterioscler Thromb Vasc Biol 2000 20 : 1323 1329.
22. Brousseau ME, O'Connor JJ Jr., Ordovas JM, et al. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial. Arterioscler Thromb Vasc Biol 2002 22 : 1148 1154.
23. Talmud PJ, Edwards KL, Turner CM, et al. Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL-C particle size. Use of a novel tetranucleotide repeat within the CETP promoter. Circulation 2000 101 : 2461 2466.
24. Freeman DJ, Griffin BA, Holmes AP, et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 1994 14 : 336 344.
25. Yamaguchi Y, Haginaka J, Morimoto S, et al. Facilitated nitration and oxidation of LDL in cigarette smokers. Eur J Clin Invest 2005 35 : 186 193.
26. Yamaguchi Y, Matsuno S, Kagota S, et al. Oxidants in cigarette smoke extract modify low-density lipoprotein in the plasma and facilitate atherogenesis in the aorta of Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 2001 156 : 109 117.
27. Hodoglugil U, Williamson DW, Huang Y, et al. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks. Clin Genet 2005 68 : 118 127.
28. Freeman DJ, Samani NJ, Wilson V, et al. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study. Eur Heart J 2003 24 : 1833 1842.
29. Liu S, Schmitz C, Stampfer MJ, et al. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men. Atherosclerosis 2002 161 : 469 474.